Orion Nutraceuticals Inc., (CSE:ORI) (the “Company” or “Orion”) announces that it will issue a total of 915,000 common shares of the Company at a deemed price of $0.10 per share to certain persons for certain consulting services provided to the Company owed totaling approximately $91,500.
The shares issued pursuant to the Agreement are subject to a four month hold period.
About Orion Nutraceuticals Inc.
Orion Nutraceuticals Inc. aims to set a new standard in cannabis life science by producing and developing innovative products with key strategic partners in the industry. In conjunction with its professional sports strategic alliances, the company is poised to advance research and development in the plant science sector, deliver science-based products and services, and market CBD therapies to the mainstream with proprietary brands and products. Orion shares trade in Canada on the CSE under the symbol ORI.
ON BEHALF OF THE BOARD
Orion Nutraceuticals Inc.
Keep up to date with Orion on our social media channels:
The CSE and Information Service Provider have not reviewed and does not accept responsibility for the accuracy or adequacy of this release.